Lauryn K Stafford
A5082737151- Health Systems, Economic Evaluations, Quality of Life
- Vaccine Coverage and Hesitancy
- Global Public Health Policies and Epidemiology
- Cardiovascular Health and Risk Factors
- Global Health Care Issues
- Chronic Disease Management Strategies
- Cardiac Imaging and Diagnostics
- Acute Ischemic Stroke Management
- Health disparities and outcomes
- COVID-19 Clinical Research Studies
- Obesity, Physical Activity, Diet
- Climate Change and Health Impacts
- Healthcare cost, quality, practices
- Viral gastroenteritis research and epidemiology
- Diagnosis and treatment of tuberculosis
- Child and Adolescent Health
- Tuberculosis Research and Epidemiology
- Cardiac, Anesthesia and Surgical Outcomes
- Healthcare Policy and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Agricultural and Rural Development Research
- Cervical Cancer and HPV Research
- Birth, Development, and Health
- Pulmonary Hypertension Research and Treatments
University of Washington
2021-2024
Institute for Health Metrics and Evaluation
2021-2024
Seattle University
2022
Diabetes is one of the leading causes death and disability worldwide, affects people regardless country, age group, or sex. Using most recent evidentiary analytical framework from Global Burden Diseases, Injuries, Risk Factors Study (GBD), we produced location-specific, age-specific, sex-specific estimates diabetes prevalence burden 1990 to 2021, proportion type 1 2 in attributable selected risk factors, projections through 2050.
<h2>Summary</h2><h3>Background</h3> Global evaluations of the progress towards WHO End TB Strategy 2020 interim milestones on mortality (35% reduction) and incidence (20% have not been age specific. We aimed to assess global, regional, national-level burdens trends in tuberculosis its risk factors across five separate groups, from 1990 2021, report age-specific between 2015 2020. <h3>Methods</h3> used Burden Diseases, Injuries, Risk Factors Study 2021 (GBD 2021) analytical framework compute...
Objectives: As little is known about the burden of type 1 (T1DM) and 2 diabetes (T2DM) in adolescents Western Europe (WE), we aimed to explore their epidemiology among 10–24 year-olds. Methods: Estimates were retrieved from Global Burden Diseases Study (GBD) 2019. We reported counts, rates per 100,000 population, percentage changes 1990 2019 for prevalence, incidence years lived with disability (YLDs) T1DM T2DM, T2DM YLDs attributable high body mass index (HBMI), 24 WE countries. Results: In...
Cost-effectiveness analysis (CEA) is a well-known, but resource intensive, method for comparing the costs and health outcomes of interventions. To build on available evidence, researchers are developing methods to transfer CEA across settings; previous do not use all results nor quantify differences settings. We conducted meta-regression published CEAs human papillomavirus (HPV) vaccination effects factors at country, intervention, method-level, predict incremental cost-effectiveness ratios...
Health care spending effectiveness is the ratio of an increase in per case illness or injury to disability-adjusted life-years (DALYs) averted case. We report US spending-effectiveness ratios, using comprehensive estimates health from Disease Expenditure Project and DALYs Global Burden Study 2017. decomposed changes over time estimate case, controlling for population size, age-sex structure, incidence prevalence cases. Across all causes disease burden, median was US$114,339 DALY between 1996...
The Ethiopian health extension program (HEP) is an innovative community-based strategy aimed at disease prevention and promotion. While workers (HEWs) are its front-line workers, the involvement of clinicians remains integral part. goals this study were to: (1) assess correlation clinician attitude with predictors (2) reliability validity survey instrument.A cross-sectional design was utilized to collect data from a sample 1239 using 28 items questions. Exploratory factor analysis (EFA)...
Rotavirus caused an estimated 151,714 deaths from diarrhea among children under 5 in 2019. To reduce mortality, countries are considering adding rotavirus vaccination to their routine immunization program. Cost-effectiveness analyses (CEAs) inform these decisions not available every setting, and where they are, results sensitive modeling assumptions, especially about vaccine efficacy. We used advances meta-regression methods estimates of efficacy by location estimate incremental...